Testing a new kind of brain scan that looks at how tumors use sugar
Original title: Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people, and it studies a scan, not a new treatment.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study checks whether a new scan can show how a brain tumor uses sugar for fuel.
Who this trial is for. This study is for people with a brain tumor who are having surgery to remove it. It tests a scan that combines MRI and PET to measure how the tumor uses sugar.
Where it stands. The study has not reported results. The team compares what the scan shows with tests done on tumor tissue taken during surgery. They also measure the acid level inside the tumor. Whether the scan matches the tissue is not known yet.
What this means, and what it doesn't
What it could mean: If this scan works, care teams may learn more about a tumor from a picture. Someone with a brain tumor who is planning surgery could ask their care team about it.
What it doesn't mean: This does not mean the scan is proven to work. A trial is a test, not care that is known to help. Being in one is not a guarantee of any benefit. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.